This invention is about an innovative hollow fiber membrane designed to improve liver cell attachment for use in bio-artificial liver systems and bioreactors and relates to a single step method for its manufacturing.

The invention involves an orally administrable pharmaceutical preparation that encapsulates proteins, specifically insulin, using metal oxide nanoparticles and amino acids.

The invention aims to create a controlled unpowered mechanical device designed to assist individuals with gait impairments—specifically targeting the heel-off phase of the stance period in walking.

This invention describes an advanced method for in-situ particulate coating on hollow fiber membranes using Graphene Oxide (GO) as the coating material.

The patented technology introduces a composite membrane designed for efficient oil-water separation.

This invention describes a robotic disinfection system designed to effectively disinfect various surfaces using ultraviolet (UV) light. The system includes disinfection arms equipped with UV lamps that emit germicidal UV light.

This innovative process provides a method and apparatus for removing polymer components from a powder-polymer mixture. The method involves immersing parts of the powder-polymer mixture in a solvent within a heated ultrasonic bath.

This invention presents a green, biocatalytic process for producing optically pure (1R,2S)-ephedrine using genetically engineered E. coli expressing the methyltransferase enzyme phenylethanolamine N-methyltransferase (PNMT).

This technology introduces a novel class of nanocomposite hollow fiber membranes (HFMs) using hydrophilic ZIF-8/GO (ZGs) nanohybrids embedded in polymer matrices such as PES.

The invention relates to high-flux, antifouling nanocomposite hollow fiber membranes made from PES, TPGS, and functionalized carbon nanotubes. These membranes offer excellent water permeability, fouling resistance, and mechanical strength.